| Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen HM Brechbuhl, J Finlay-Schultz, TM Yamamoto, AE Gillen, DM Cittelly, ... Clinical Cancer Research 23 (7), 1710-1721, 2017 | 227 | 2017 |
| The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ... Nature medicine 27 (2), 310-320, 2021 | 200 | 2021 |
| Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures P Kabos, J Finlay-Schultz, C Li, E Kline, C Finlayson, J Wisell, CA Manuel, ... Breast cancer research and treatment 135, 415-432, 2012 | 159 | 2012 |
| Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4 DM Cittelly, J Finlay-Schultz, EN Howe, NS Spoelstra, SD Axlund, ... Oncogene 32 (20), 2555-2564, 2013 | 139 | 2013 |
| Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia SH Stephens, J Logel, A Barton, A Franks, J Schultz, M Short, ... Schizophrenia research 109 (1-3), 102-112, 2009 | 127 | 2009 |
| Steroid hormones, steroid receptors, and breast cancer stem cells J Finlay-Schultz, CA Sartorius Journal of mammary gland biology and neoplasia 20, 39-50, 2015 | 110 | 2015 |
| Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a J Finlay-Schultz, DM Cittelly, P Hendricks, P Patel, P Kabos, BM Jacobsen, ... Oncogene 34 (28), 3676-3687, 2015 | 93 | 2015 |
| The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis EA Wellberg, S Johnson, J Finlay-Schultz, AS Lewis, KL Terrell, ... Breast Cancer Research 18, 1-15, 2016 | 72 | 2016 |
| Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III J Finlay-Schultz, AE Gillen, HM Brechbuhl, JJ Ivie, SB Matthews, ... Cancer research 77 (18), 4934-4946, 2017 | 68 | 2017 |
| New generation breast cancer cell lines developed from patient-derived xenografts J Finlay-Schultz, BM Jacobsen, D Riley, KV Paul, S Turner, ... Breast Cancer Research 22, 1-12, 2020 | 37 | 2020 |
| Fibroblast subtypes define a metastatic matrisome in breast cancer HM Brechbuhl, AS Barrett, E Kopin, JC Hagen, AL Han, AE Gillen, ... JCI insight 5 (4), 2020 | 34 | 2020 |
| Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells LM Fettig, O McGinn, J Finlay-Schultz, DV LaBarbera, SK Nordeen, ... Oncogene 36 (44), 6074-6084, 2017 | 34 | 2017 |
| Cytokeratin 5 alters β-catenin dynamics in breast cancer cells O McGinn, AV Ward, LM Fettig, D Riley, J Ivie, KV Paul, P Kabos, ... Oncogene 39 (12), 2478-2492, 2020 | 27 | 2020 |
| Promoter Methylation and Tissue-Specific Transcription of the α7 Nicotinic Receptor Gene, CHRNA7 A Canastar, J Logel, S Graw, J Finlay-Schultz, C Osborne, M Palionyte, ... Journal of Molecular Neuroscience 47, 389-400, 2012 | 23 | 2012 |
| Labeling of breast cancer patient-derived xenografts with traceable reporters for tumor growth and metastasis studies C Hanna, L Kwok, J Finlay-Schultz, CA Sartorius, DM Cittelly JoVE (Journal of Visualized Experiments), e54944, 2016 | 20 | 2016 |
| Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries KA Riemondy, M Ransom, C Alderman, AE Gillen, R Fu, J Finlay-Schultz, ... Nucleic acids research 47 (4), e20-e20, 2019 | 19 | 2019 |
| Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α) J Finlay-Schultz, A Canastar, M Short, M El Gazzar, C Coughlan, ... Journal of Biological Chemistry 286 (49), 42123-42132, 2011 | 18 | 2011 |
| Exogenous thyroid hormone is associated with shortened survival and upregulation of high-risk gene expression profiles in steroid receptor–positive breast cancers RS Wahdan-Alaswad, SM Edgerton, H Salem, HM Kim, AC Tan, ... Clinical Cancer Research 27 (2), 585-597, 2021 | 12 | 2021 |
| Cytokeratin 5–positive cells represent a therapy resistant subpopulation in epithelial ovarian cancer BR Corr, J Finlay-Schultz, RB Rosen, L Qamar, MD Post, K Behbakht, ... International Journal of Gynecological Cancer 25 (9), 1565-1573, 2015 | 12 | 2015 |
| Estrogens and progestins cooperatively shift breast cancer cell metabolism AV Ward, SB Matthews, LM Fettig, D Riley, J Finlay-Schultz, KV Paul, ... Cancers 14 (7), 1776, 2022 | 9 | 2022 |
Carol A SartoriusUniversity of Colorado Anschutz Medical Campus在 ucdenver.edu 的电子邮件经过验证
